Stockscreener 앱 받기
0.5957
1.89%
-0.0128
전일 마감가:
$0.6085
열려 있는:
$0.61
하루 거래량:
96,253
Relative Volume:
0.25
시가총액:
$23.27M
수익:
-
순이익/손실:
$-17.78M
주가수익비율:
-1.0847
EPS:
-0.5492
순현금흐름:
$-10.52M
1주 성능:
-1.63%
1개월 성능:
-2.45%
6개월 성능:
-63.82%
1년 성능:
-84.21%
1일 변동 폭
$0.5813
$0.6299
1주일 범위
$0.5801
$0.658
52주 변동 폭
$0.5801
$4.41
Fibrobiologics Inc Stock (FBLG) Company Profile
명칭
Fibrobiologics Inc
전화
281-671-5150
주소
455 E. MEDICAL CENTER BLVD, HOUSTON
FBLG을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FBLG
Fibrobiologics Inc
|
0.5864 | 26.85M | 0 | -17.78M | -10.52M | -0.5492 |
|
VRTX
Vertex Pharmaceuticals Inc
|
399.07 | 118.67B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.83 | 59.23B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
424.85 | 52.67B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
693.68 | 41.24B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
306.17 | 32.36B | 3.81B | -644.79M | -669.77M | -6.24 |
Fibrobiologics Inc Stock (FBLG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-12 | 개시 | Rodman & Renshaw | Buy |
| 2024-10-30 | 개시 | H.C. Wainwright | Buy |
| 2024-09-24 | 개시 | Maxim Group | Buy |
Fibrobiologics Inc 주식(FBLG)의 최신 뉴스
How many analysts rate FibroBiologics Inc. as a “Buy”Invest confidently with expert support - Jammu Links News
What are analysts’ price targets for FibroBiologics Inc. in the next 12 monthsSky-high profits - Jammu Links News
Is it the right time to buy FibroBiologics Inc. stockCapitalize on market shifts with expert advice - Jammu Links News
Is FibroBiologics Inc. a growth stock or a value stockAccess high-quality stock research instantly - Jammu Links News
FibroBiologics Inc. Stock Analysis and ForecastHigh-performance stocks for savvy investors - Jammu Links News
What catalysts could drive FibroBiologics Inc. stock higher in 2025Build a diversified portfolio for sustainable growth - Jammu Links News
How does FibroBiologics Inc. compare to its industry peersUnlock exclusive stock analysis for investors - Jammu Links News
What analysts say about FibroBiologics Inc. stockCapitalize on market shifts before others do - Jammu Links News
Is FibroBiologics Inc. a good long term investmentTriple returns potential - Jammu Links News
What is the dividend policy of FibroBiologics Inc. stockFree Wealth Management Insights - Jammu Links News
What makes FibroBiologics Inc. stock price move sharplyFree Stock Index Interpretation - Jammu Links News
What are the latest earnings results for FibroBiologics Inc.Invest smarter with data-backed insights - Jammu Links News
Should I hold or sell FibroBiologics Inc. stock in 2025Achieve breakthrough financial results today - Jammu Links News
What are the technical indicators suggesting about FibroBiologics Inc.Dynamic investment growth - Jammu Links News
What institutional investors are buying FibroBiologics Inc. stockCapitalize on emerging growth stocks - Jammu Links News
How strong is FibroBiologics Inc. company’s balance sheetBuild a diversified portfolio for maximum returns - Jammu Links News
Has FibroBiologics Inc. found a price floorFree Portfolio Diversification Stock Ideas - Newser
Multi asset correlation models including FibroBiologics Inc.Weekly Signal Report with Trend Summary - Newser
Published on: 2025-08-01 21:09:45 - Newser
Fibrobiologics, Inc. shares fall 1.41% intraday after reporting Q2 2025 earnings and closing a $5 million financing tranche. - AInvest
Key metrics from FibroBiologics Inc.’s quarterly dataFree Secure Return Focused Investment Plan - Newser
Using portfolio simulators with FibroBiologics Inc. includedLong-Term Investment Strategy Impact Analysis - Newser
FibroBiologics’ (FBLG) Buy Rating Reiterated at D. Boral Capital - Defense World
Published on: 2025-08-01 00:21:42 - Newser
Analyzing drawdowns of FibroBiologics Inc. with statistical toolsTechnical Setup and Return Forecast Engine - Newser
FibroBiologics Announces 1H Results: Net Loss of $9.6mln, Cash at $8.8mln - AInvest
FibroBiologics Q2 2025 Earnings Release: Negative Earnings Amid Industry-Wide Skepticism - AInvest
FibroBiologics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
FibroBiologics Raises $5M, Fast-Tracks Revolutionary Fibroblast Therapy for Diabetic Foot Ulcers - Stock Titan
Building trade automation scripts for FibroBiologics Inc.Free Conservative Long Term Growth Plans - Newser
How FibroBiologics Inc. stock performs during market volatilityHigh Return Strategy with Low Risk - Newser
Using data filters to optimize entry into FibroBiologics Inc.AI Screener for Daily Stock Forecast - Newser
Investors Hope for Bounce in FibroBiologics Inc. After SelloffStep-by-Step Stock Investment Guide Gains Popularity - beatles.ru
Published on: 2025-07-30 00:29:07 - metal.it
Heatmap Data Shows High Activity in FibroBiologics Inc. SectorHigh Win Rate Trading Opportunities Detected - metal.it
FibroBiologics: D. Boral Capital maintains Buy, raises PT to $16 from $15. - AInvest
Price Reversal in FibroBiologics Inc. Traders Watch CloselyFast Return Equity Trade Forecast Points to Small Caps - metal.it
Strategies to average down on FibroBiologics Inc.Sector Rotation and Stock Opportunity Analysis - Newser
Fibrobiologics, Inc. shares rise 2.13% after-hours after filing a patent for generating multipotent cells from fibroblasts. - AInvest
FibroBiologics files patent application on generating multipotent cells - TipRanks
Fibrobiologics, Inc. shares fall 2.66% intraday after filing a patent application for generating multipotent cells from fibroblasts. - AInvest
Orthopediatrics Corp. shares fall 1.28% intraday as FibroBiologics files patent for multipotent cell generation. - AInvest
FibroBiologics files patent for multipotent cell generation method - Investing.com Australia
FibroBiologics files patent for multipotent cell generation method By Investing.com - Investing.com India
Fibrobiologics Inc (FBLG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.15%
1.60%
자본화:
|
볼륨(24시간):